The observed alterations in nutrient usage in T2D CD8+ EMRA T cells led us to examine the levels of phosphorylated AMP-activated protein kinase (pAMPK), a master regulator of both glucose and lipid metabolism (Hardie et al., 2012). This evidence concerns the gene CD8A and type 2 diabetes mellitus.